EASTMAN CHEMICAL Q2 FY26 earnings call EMN

The Advanced Materials segment delivered solid 5% volume and mix growth in Q2 FY26, driven by innovation wins and ramping circular business volumes. While weak end markets like OEM production and consumer durables persist, management expects volumes in Q3 to be similar to Q2, representing a substantial year-over-year increase. Asset utilization is anticipated to be a tailwind in H2, reversing a H1 headwind, as the new Triton line comes online and paraxylene inventory is converted to finished goods. Price/cost actions are also expected to provide a tailwind in the second half.

The circular economy business saw revenue growth exceeding $100 million in H1 FY26, doubling year-over-year, split evenly between specialty and PET growth. The Kingsport methanolysis plant is performing exceptionally well, with yields above 90% and identified debottlenecking potential to increase capacity by 30% to 130,000 tons. While the full-year circular revenue outlook was slightly adjusted due to minor capacity limitations and broader market slowness, the long-term EBITDA potential of $200 million for the first asset remains intact. The next major capital investment for methanolysis is being pushed out to 2028 for better market alignment.

Chemical Intermediates experienced a robust volume increase in Q2, primarily due to fewer significant shutdowns compared to last year. This included some market share gains in North America and attractive export markets due to supply tightness. The segment also benefited from storing ethylene in caverns at attractive prices. However, the outlook for H2 margins is uncertain, with potential moderation due to the Middle East conflict, though the situation remains highly dynamic.

The Additives & Functional Products segment demonstrated remarkable margin resilience, underpinned by its focus on stable end markets such as pharma, water treatment, ag, personal care, and aviation, which constitute two-thirds of its revenue. These markets feature strong industry structures, competitive positions, and cost pass-through contracts, providing significant margin stability. Effective price increases consistent with raw material costs have further supported margins.

The Fibers business faces mixed dynamics. Tow volumes are expected to increase materially in H2 as customers meet annual minimum commitments, stabilizing full-year volumes relative to last year. However, the textile business remains challenging, with low volumes in H1 and a tough comparison to last year. While some recovery is anticipated in H2, full-year textile volumes are expected to be flat year-over-year. Management is implementing actions to stabilize the business, including recovering market share and leveraging growth programs, to improve performance in FY27.

Eastman maintains a disciplined approach to portfolio management, including successful divestitures and strategic acquisitions. The company believes it has reached minimum scale for effective innovation and balance sheet support. The M&A market has seen increased activity and more rational valuations, prompting Eastman to actively consider options while emphasizing continued discipline in both acquisitions and divestitures, aligning with anticipated industry changes over the coming years.

Eastman highlighted strong innovation-driven growth across its portfolio, particularly in Advanced Materials. Key successes include new growth in Triton, increased conversion to products due to BPA bans in Europe, a new recycled code 1 cosmetic product, and an expanded performance films strategy in China. In AFP, ultra high-purity solvents for semiconductors and new biodegradable polymer coatings for paper are contributing to growth. Innovation-derived revenue is estimated to be in the mid-teens to 20% range within specialty businesses.